- Prison Planet.com - http://www.prisonplanet.com -

Dr. Burzynski’s Cancer Research Institute Threatens Big Pharma

Posted By yihan On November 11, 2011 @ 9:01 am In Featured Stories | Comments Disabled

TheAlexJonesChannel [1]
Friday, November 11, 2011

Mike Adams from NaturalNews.com, reporting for Infowars.com visits the Burzynski research institute and speaks with Dr. Stanislaw Burzynski, founder of the research institute and clinic. Dr. Burzynski talks about how his invention of gene-targeted cancer medications called Antineoplastons has shown much greater success rates for ridding the body of cancer than any conventional method. Dr. Burzynski also explains that while his invention should be applauded by the medical industry as a whole, it actually made him a target of scrutiny and many indictments.


Article printed from Prison Planet.com: http://www.prisonplanet.com

URL to article: http://www.prisonplanet.com/dr-burzynskis-cancer-research-institute-threatens-big-pharma.html

URLs in this post:

[1] TheAlexJonesChannel: http://www.youtube.com/watch?v=TX4cTKIqizE&feature=channel_video_title

[2] Cancer Institute Warns of Cell Phone Risks: http://www.prisonplanet.com/cancer-institute-warns-of-cell-phone-risks.html

[3] Research: Gold and Tea Outperform Chemo in Fighting Cancer: http://www.prisonplanet.com/research-gold-and-tea-outperform-chemo-in-fighting-cancer.html

[4] The cancer industry’s war on cancer cures: http://www.prisonplanet.com/the-cancer-industrys-war-on-cancer-cures.html

[5] Evidence suggests that up to 90 percent of landmark cancer research may be false: http://www.prisonplanet.com/evidence-suggests-that-up-to-90-percent-of-landmark-cancer-research-may-be-false.html

[6] 8000 IUs of vitamin D daily necessary to raise blood levels of “miracle” anti-cancer nutrient, declares groundbreaking new research: http://www.prisonplanet.com/8000-ius-of-vitamin-d-daily-necessary-to-raise-blood-levels-of-miracle-anti-cancer-nutrient-declares-groundbreaking-new-research.html

Copyright © 2013 PrisonPlanet.com. All rights reserved.